Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relmada Therapeutics (RLMD) Current Assets (2016 - 2026)

Relmada Therapeutics has reported Current Assets over the past 3 years, most recently at $8750.0 for Q1 2014.

  • Quarterly Current Assets fell 14.17% to $8750.0 in Q1 2014 from the year-ago period, while the trailing twelve-month figure was $8750.0 through Feb 2014, down 14.17% year-over-year, with the annual reading at $18459.0 for FY2013, 0.57% up from the prior year.
  • Current Assets was $8750.0 for Q1 2014 at Relmada Therapeutics, down from $10900.0 in the prior quarter.
  • Over five years, Current Assets peaked at $18459.0 in Q3 2013 and troughed at $3033.0 in Q2 2013.
  • The 3-year median for Current Assets is $10547.0 (2013), against an average of $11615.0.
  • Year-over-year, Current Assets rose 0.57% in 2013 and then fell 14.17% in 2014.
  • A 3-year view of Current Assets shows it stood at $18354.0 in 2012, then crashed by 40.61% to $10900.0 in 2013, then dropped by 19.72% to $8750.0 in 2014.
  • Per Business Quant, the three most recent readings for RLMD's Current Assets are $8750.0 (Q1 2014), $10900.0 (Q4 2013), and $18459.0 (Q3 2013).